Keep the Right in Mind-A Focused Approach to Right Ventricle-Predominant Cardiogenic Shock

Overview

Journal Life (Basel)

Specialty Biology

Date 2023 Feb 25

PMID 36836735

Authors

Viana Jacquline Copeland

Alexander Fardman

Ariel Furer

Affiliations

Soon will be listed here.

Abstract

Cardiogenic shock (CS) remains a highly lethal condition despite many efforts and new interventions. Patients presenting with a rapid onset of hemodynamic instability and subsequent collapse require prompt and appropriate multimodality treatment. Multiple etiologies can lead to heart failure and subsequent shock. As the case prevalence of heart failure increases worldwide, it is of great importance to explore all manners and protocols of presentation and treatment present. With research primarily focusing on CS due to cardiac left-sided pathology, few assessments of right-sided pathology and the subsequent clinical state and treatment have been conducted. This review aims to present an in-depth assessment of the currently available literature, assessing the pathophysiology, presentation and management of CS patients due to right heart failure.

Citing Articles

Successful pharmaco-invasive approach using a lower alteplase dose and VA-ECMO support in high-risk pulmonary embolism: case report.

Gutierrez-Gallegos P, Jimenez-Franco V, Jerjes-Sanchez C, Quevedo-Salazar R, Rodriguez-Rivera J, Paredes-Gutierrez E Front Cardiovasc Med. 2024; 11:1444636.

PMID: 39105076 PMC: 11298445. DOI: 10.3389/fcvm.2024.1444636.

References

Roger V . Epidemiology of heart failure. Circ Res. 2013; 113(6):646-59. PMC: 3806290. DOI: 10.1161/CIRCRESAHA.113.300268. View

Kanwar M, Everett K, Gulati G, Brener M, Kapur N . Epidemiology and management of right ventricular-predominant heart failure and shock in the cardiac intensive care unit. Eur Heart J Acute Cardiovasc Care. 2022; 11(7):584-594. DOI: 10.1093/ehjacc/zuac063. View

Rudski L, Lai W, Afilalo J, Hua L, Handschumacher M, Chandrasekaran K . Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology,.... J Am Soc Echocardiogr. 2010; 23(7):685-713. DOI: 10.1016/j.echo.2010.05.010. View

van Diepen S, Katz J, Albert N, Henry T, Jacobs A, Kapur N . Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association. Circulation. 2017; 136(16):e232-e268. DOI: 10.1161/CIR.0000000000000525. View

Deniau B, Picod A, Azibani F, Gayat E, Mebazaa A, Blet A . The CLIP-based mortality score in cardiogenic shock: suitable only for cardiogenic shock?. Eur J Heart Fail. 2021; 23(7):1240-1242. DOI: 10.1002/ejhf.2208. View

Kostura M, Smalley C, Koyfman A, Long B . Right heart failure: A narrative review for emergency clinicians. Am J Emerg Med. 2022; 58:106-113. DOI: 10.1016/j.ajem.2022.05.030. View

Levy B, Clere-Jehl R, Legras A, Morichau-Beauchant T, Leone M, Frederique G . Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction. J Am Coll Cardiol. 2018; 72(2):173-182. DOI: 10.1016/j.jacc.2018.04.051. View

Levy B, Klein T, Kimmoun A . Vasopressor use in cardiogenic shock. Curr Opin Crit Care. 2020; 26(4):411-416. DOI: 10.1097/MCC.0000000000000743. View

Cassady S, Ramani G . Right Heart Failure in Pulmonary Hypertension. Cardiol Clin. 2020; 38(2):243-255. DOI: 10.1016/j.ccl.2020.02.001. View

10.

Topalian S, Ginsberg F, Parrillo J . Cardiogenic shock. Crit Care Med. 2008; 36(1 Suppl):S66-74. DOI: 10.1097/01.CCM.0000296268.57993.90. View

11.

Krishnamoorthy A, DeVore A, Sun J, Barnett A, Samsky M, Shaw L . The impact of a failing right heart in patients supported by intra-aortic balloon counterpulsation. Eur Heart J Acute Cardiovasc Care. 2016; 6(8):709-718. DOI: 10.1177/2048872616652262. View

12.

Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R . PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock. N Engl J Med. 2017; 377(25):2419-2432. DOI: 10.1056/NEJMoa1710261. View

13.

Schrage B, Westermann D . Mechanical circulatory support devices in cardiogenic shock and acute heart failure: current evidence. Curr Opin Crit Care. 2019; 25(4):391-396. DOI: 10.1097/MCC.0000000000000629. View

14.

Muzevich K, Chohan H, C Grinnan D . Management of pulmonary vasodilator therapy in patients with pulmonary arterial hypertension during critical illness. Crit Care. 2015; 18(5):523. PMC: 4331447. DOI: 10.1186/s13054-014-0523-z. View

15.

Chia Y, Kieneker L, van Hassel G, Binnenmars S, Nolte I, van Zanden J . Interleukin 6 and Development of Heart Failure With Preserved Ejection Fraction in the General Population. J Am Heart Assoc. 2021; 10(11):e018549. PMC: 8483531. DOI: 10.1161/JAHA.120.018549. View

16.

Binanay C, Califf R, Hasselblad V, OConnor C, Shah M, Sopko G . Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA. 2005; 294(13):1625-33. DOI: 10.1001/jama.294.13.1625. View

17.

Doherty S . Pulmonary embolism An update. Aust Fam Physician. 2017; 46(11):816-820. View

18.

Fried J, Nair A, Takeda K, Clerkin K, Topkara V, Masoumi A . Clinical and hemodynamic effects of intra-aortic balloon pump therapy in chronic heart failure patients with cardiogenic shock. J Heart Lung Transplant. 2018; 37(11):1313-1321. PMC: 6148415. DOI: 10.1016/j.healun.2018.03.011. View

19.

Pfisterer M . Right ventricular involvement in myocardial infarction and cardiogenic shock. Lancet. 2003; 362(9381):392-4. DOI: 10.1016/S0140-6736(03)14028-7. View

20.

Anderson M, Goldstein J, Milano C, Morris L, Kormos R, Bhama J . Benefits of a novel percutaneous ventricular assist device for right heart failure: The prospective RECOVER RIGHT study of the Impella RP device. J Heart Lung Transplant. 2015; 34(12):1549-60. DOI: 10.1016/j.healun.2015.08.018. View